Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
BRIEF-Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance Oct 12 (Reuters) - Bausch Health Companies Inc. BHC.TO:
BAUSCH + LOMB AND BAUSCH HEALTH ANNOUNCE APPOINTMENT OF THOMAS J. APPIO AS INTERIM BAUSCH + LOMB CEO, EXPECT TO RAISE FULL-YEAR 2026 GUIDANCE
BAUSCH + LOMB - BRENT SAUNDERS TO DEPART AS CEO OF BAUSCH + LOMB
BAUSCH + LOMB - EXPECT TO RAISE FULL-YEAR 2026 ADJUSTED EBITDA EXCLUDING BOUGHT IPR&D GUIDANCE
Source text: ID:nBw7rjGMDa
Further company coverage: BHC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bausch Health Companies
See all newsCanada Stocks: TSX inches lower as tech and mining shares fall
Bausch Health Companies Inc. reports results for the quarter ended September 30 - Earnings Summary
Brief: Bausch Health Announces Full Redemption Of 8.500% Senior Notes Due 2027
Brief: Bausch Health Announces $50 Million Share Repurchase Program
Brief: Bausch Health Announces $50 Million Share Repurchase Program